Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. The... Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States. Mehr anzeigen
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has...
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™...
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.23 | 10.502283105 | 2.19 | 2.54 | 2.17 | 506176 | 2.30315034 | CS |
| 4 | 0.09 | 3.86266094421 | 2.33 | 2.7155 | 2.03 | 411700 | 2.28939465 | CS |
| 12 | 0.53 | 28.0423280423 | 1.89 | 2.7155 | 1.82 | 421846 | 2.24284507 | CS |
| 26 | 0.43 | 21.608040201 | 1.99 | 2.7155 | 1.68 | 286832 | 2.16275334 | CS |
| 52 | 0.35 | 16.9082125604 | 2.07 | 3.29 | 1.66 | 289854 | 2.2812088 | CS |
| 156 | -2.69 | -52.6418786693 | 5.11 | 5.64 | 1.33 | 269360 | 2.22432634 | CS |
| 260 | -2.12 | -46.6960352423 | 4.54 | 10.3 | 1.33 | 283657 | 3.82683984 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,02 (-0,48%) | 102,62M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5,82 (1,39%) | 81,2M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,3017 (-2,26%) | 75,38M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,565 (7,70%) | 70,73M |
| SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 20,61 (0,73%) | 67,41M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
